G9071 Onc diagnosis brst stg1-2b hr,nopro
Also known as: hormone-positive breast cancer early, HR+ breast cancer stage 1-2
Performance measure documenting breast cancer stage 1-2B, hormone receptor positive, without evidence of disease progression.
In Plain Language
early breast cancer that is hormone-sensitive; stage 1-2 breast cancer with hormone receptor
Clinical Context
Quality measure documenting early-stage hormone receptor-positive breast cancer for endocrine therapy planning.
RVU Information
CPT G9071 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9071?
CPT G9071 (Onc diagnosis brst stg1-2b hr,nopro) is a G Codes code. Performance measure documenting breast cancer stage 1-2B, hormone receptor positive, without evidence of disease progression.
Who uses CPT code G9071?
CPT G9071 is used by Surgical Oncology, Medical Oncology. Quality measure documenting early-stage hormone receptor-positive breast cancer for endocrine therapy planning.
When is CPT G9071 used?
Quality measure documenting early-stage hormone receptor-positive breast cancer for endocrine therapy planning.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.